You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Genenta Science S.p.A. will operate as Saentra Forge, with its ADSs expected to begin trading under ticker symbol “SAEN” on November 4, 2026, subject to final Nasdaq confirmation. The Board approved both changes on October 20, 2026.
On October 19, 2026, the Tribunal of Milan suspended Genenta Science S.p.A.’s resolution appointing its Board of Directors, causing the prior Board to resume in a prorogatio regime; the company plans to appeal.
Genenta Science S.p.A. received Nasdaq’s minimum bid price deficiency notice after its ADS closing bid remained below $1.00 per ADS for 30 consecutive business days. Nasdaq granted 180 calendar days, until April 14, 2027, to regain compliance.
Genenta Science S.p.A.’s shareholders did not approve the proposed change of its legal name to Saentra Forge S.p.A. on October 8, 2026, so the registered name remains unchanged. The company continues pursuing its strategic transition toward acquiring established industrial businesses.
Genenta Science S.p.A.’s capital increase for its A.T.C. S.r.l. acquisition remains effective after the Court of Milan denied minority shareholders’ interim-suspension application in an order dated October 2, 2026; the merits case remains pending and the order may be appealed.
